QTTB
Q32 Bio Inc.
NASDAQ · Healthcare · Biotechnology · US
$8.89
+1.48%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 529.30x
Trailing multiples
Trailing twelve months
- P/E TTM
- 3.19x
- PEG TTM
- —
- Price / book
- 2.50x
- Price / sales
- 4.92x
- Price / cash flow
- -13.35x
Enterprise value
- Enterprise value
- $163.7M
- EV / sales
- 3.05x
- EV / EBITDA
- 4.74x
- EV / EBIT
- 7.63x
- Market cap
- $264.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026